Hepatitis C virus infection in Ghana: time for action is now

  • Kenneth Tachi


Chronic hepatitis C virus (HCV) infection is a blood borne infection just like hepatitis B virus (HBV) and Human Immunodeficiency Virus (HIV) with a significant global health impact. Since the discovery of the HCV, several developments including a better understanding of the clinical epidemiology, availability of diagnostics and approval of newer therapies over the last decade have occurred and changed the frontiers of HCV management. Many nations now place HCV infection as a priority public health issue. In Ghana however, awareness, advocacy and treatment of HCV still plays a second fiddle to HBV and HIV. This must change and the time to act is now.

Author Biography

Kenneth Tachi

Lecturer, Department of Medicine and Therapeutics, School of Medicine & Dentistry, College of Health Sciences, University of Ghana, Accra, Ghana


Journal Identifiers

print ISSN: 0016-9560